Your browser doesn't support javascript.
loading
The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells.
Lapinska, Karolina; Housman, Genevieve; Byler, Shannon; Heerboth, Sarah; Willbanks, Amber; Oza, Anuja; Sarkar, Sibaji.
Affiliation
  • Lapinska K; Cancer Center, Department of Medicine, Boston University School of Medicine, Boston, MA, U.S.A.
  • Housman G; Quinnipiac University School of Medicine, North Haven, CT, U.S.A.
  • Byler S; School of Human Evolution and Social Change, Arizona State University, Tempe, AZ, U.S.A.
  • Heerboth S; Department of Pediatrics, Children's Hospital/Harvard Medical School, Boston, MA, U.S.A.
  • Willbanks A; Vanderbilt University School of Medicine, Nashville, TN, U.S.A.
  • Oza A; Cancer Center, Department of Medicine, Boston University School of Medicine, Boston, MA, U.S.A.
  • Sarkar S; Cancer Center, Department of Medicine, Boston University School of Medicine, Boston, MA, U.S.A.
Anticancer Res ; 36(11): 5731-5742, 2016 11.
Article in En | MEDLINE | ID: mdl-27793894
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Glycoproteins Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Anticancer Res Year: 2016 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Glycoproteins Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Anticancer Res Year: 2016 Type: Article Affiliation country: United States